Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
During 2022, the med-tech company PolarCool AB (publ) established an installed a base of 38 PolarCap® Systems in Europe. This means that the number of installed systems has doubled during the year. At the same time, the company estimates that the rental of new systems will increase and by the end of 2023 amount to 100-150 systems. The income from 150 rented systems is expected to cover the company's cost base with current operations. However, PolarCool expects to achieve FDA approval during the year, which in that case will mean an investment into the USA and thus increased costs.
-During 2022, we have seen a good increase in the number of rented systems. As the publication of the study in the Journal of Neurotrauma has led to an increase in interest for the PolarCap System we see an increase in our pipeline of new potential customers. That, in combination with the significant work already put into market awareness of PolarCap, leads us to have a positive view of our growth and an expectation of an increased number of new customers. At the same time, our costs will decrease significantly when we get our own Quality Management System certified, which is expected to happen during the third quarter, 2023, says Erik Andersson, CEO of PolarCool.
A summary of the year's market expansion and activities, as well as the company's view of the progress, is published on the company's website, www.polarcool.se. The full summary is also attached as an appendix to this press release.
The summary covers, among other things, the following points:
- The importance of the new scientific evidence for the treatment with the PolarCap System.
- The positive financial aspects for clubs implementing the PolarCap System
- Current status regarding PolarCool's sales and expansion in Europe
- New potential markets for the PolarCap System in 2023
- The increased attention to the problems with concussions
- Sales target and forecast
This information is information that PolarCool (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out herein, on January 2[nd], 2023.